Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults

Circulation

Volumn 98, Issue 18, 1998, Pages 1848-1852

  Bellamy, M F ^a   McDowell, I F W ^a   Ramsey, M W ^a   Brownlee, M ^a   Bones, C ^a   Newcombe, R G ^a   Lewis, Malcolm J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Endothelium; Homocysteine; Methionine; Vasodilation

Indexed keywords

HOMOCYSTEINE; METHIONINE;

ADULT; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0032480790     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.18.1848     Document Type: Article

References (29)

1. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 1995;274:1049-1057.
2. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York, NY: McGraw Hill; 1995:1279-1327.
3. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
4. 6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1993;57:47-53.
5. Sardharwalla IB, Fowler B, Robins AJ, Komrower GM. Detection of heterozygotes for homocystinuria: study of sulphur-containing amino acids in plasma and urine after L-methionine loading. Arch Dis Child. 1974;49:553-559.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 1993;362:801-809.
7. Wall RT, Harlan JM, Harker LA, Striker GE. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res. 1980;18:113-121.
8. Dudman NPB, Hicks C, Wang J, Wilcken DEL. Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis. 1991;91:77-83.
9. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest. 1996;98:24-29.
10. Celermajer DS, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not their heterozygous parents. J Am Coll Cardiol. 1993;22:854-858.
11. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 1997;95:1119-1121.
12. Bellamy MF, Ramsey MW, Goodfellow J, Brownlee M, Gorman S, McDowell IF, Lewis MJ. Hyperhomocysteinemia and endothelial dysfunction with low vitamin B12/folate status. Circulation. 1996;94(suppl I):I-462. Abstract.
13. Woo KS, Chook P, Lolin YI, Cheung ASP, Chan LT, Sun YY, Sanderson JE, Metreweli C, Celermajer DS. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation. 1997;96: 2542-2544.
14. Ramsey MW, Goodfellow J, Jones CHJ, Luddington LA, Lewis MJ, Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation. 1995;92:3212-3219.
15. Kuo AK, Still R, Cale S, McDowell IFW. Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem. 1997;43: 1653-1655.
16. Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979;8:7-20.
17. Mansoor MA, Svardal AM, Schneede J, Ueland PM. Dynamic relation between reduced, oxidised, and protein-bound homocysteine and other thiol components in plasma during methionine loading in healthy men. Clin Chem. 1992;38:1316-1321.
18. Joannides R, Haefeli W, Linder L, Richard V, Bakkali FH, Thuillez C, Lüscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91: 1314-1319.
19. Celermajer DS, Sorenson KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan JD, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:111 1-1115.
20. Corretti MC, Plotnick GD, Vogel RA. Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound. Am J Physiol. 1995;268:H1397-H1404.
21. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrage D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulation. J Am Coll Cardiol. 1995;26:1235-1241.
22. Tsai JC, Perrella MA, Yoshizumi M, Hseih CM, Haber E, Schlegel R, Lee ME. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91: 6369-6373.
23. Rees MM, Rodgers GM. Homocysteinaemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res. 1993;71: 337-359.
24. Hirano K, Ogihara T, Miki M, Yasuda H, Tamai H, Kawamura N, Mino M. Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol. Free Radic Res. 1994;21:267-276.
25. Olszewski AJ, McCully KS. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic Biol Med. 1993;14: 683-693.
26. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 1986;77:1370-1376.
27. Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, Robinson K, Dennis VW. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation. 1998;97:138-141.
28. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylene-tetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet. 1991;48:536-545.
29. Guttormsen AB, Ueland PM, Nesthus I, Nygard O, Schneede J, Vollsef SE, Refsum H. Determinants of vitamin responsiveness of intermediate hyperhomocysteinemia (≥40 μmol/liter). J Clin Invest. 1996;98: 2174-2183.